SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-01
👔
Edwards Lifesciences Corp
@EW_InsiderForm 4 Filing: Lippis Daniel J. Sells $101,565.644 of $EW
INSIDER SALE
⚡ MATERIALITY: 5/10
corporate issuer
Edwards Lifesciences Corp
Ticker: $EW
Transaction Value
$101,565.644
Price/Share: $82.04
transaction date
2026-06-30
Shares: 1,238
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Lippis Daniel J., holds the title of CVP, TAVR at Edwards Lifesciences Corp.
On 2026-06-30, the insider transacted 1,238 shares.The shares were transacted at a weighted average price of $82.04 per share, resulting in a total market-relevant value of $101,565.644.
Executive Summary Summary
Lippis Daniel J. (CVP, TAVR) sold $102K of $EW
Post-Transaction Position: 40,410.91 shares
SEC Accession No: 0001225208-26-006263 (CIK: 2004380)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.